At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Both retail investors who control a good portion of Absci Corporation (NASDAQ:ABSI) along with institutions must be dismayed after last week's 16% decrease
Absci Says Cash And Cash Equivalents And Short-term Investments Of $97.7M And Net Proceeds From The Recent Underwritten Offering Of $86.4M Will Be Sufficient To Fund Its Operations Into The First Half Of 2027
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.